Form 4: STERIS SVP Mary Clare Fraser Reports Stock Withholding

STERIS plc SVP and Chief HRO Mary Clare Fraser reported the withholding of 311 shares to cover tax obligations upon the vesting of restricted stock.

Summary

• Mary Clare Fraser, SVP & Chief HRO of STERIS plc, executed a transaction on June 3, 2026.
• The transaction involved the withholding of 311 ordinary shares to satisfy tax withholding requirements related to the vesting of 835 restricted shares.
• The shares were valued at $210.19 per share, based on the NYSE closing price on the date of vesting.
• Following this transaction, the reporting person maintains a beneficial ownership of 14,316 ordinary shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a routine tax-related transaction by an executive rather than a market-moving event.

Positives

• The transaction is a routine administrative action related to tax obligations upon equity vesting rather than a discretionary sale.
• The reporting person retains a significant equity stake of 14,316 shares in the company.

Negatives

• None identified; this is a standard regulatory filing for tax compliance.

Risks

• None identified; this filing pertains to internal tax withholding procedures.

Future Outlook

The filing outlines a schedule for the future lapse of restrictions on 6,719 shares through June 4, 2029.

Industry Context

StockSavvy.ai notes that this is a standard administrative filing common among publicly traded companies, reflecting routine executive compensation management rather than a change in strategic outlook or market sentiment.

Comparison to Industry Standards

• The transaction follows standard corporate governance practices for equity-based compensation.
• Tax withholding via share reduction is a common industry practice for medical device and healthcare companies like STERIS.

Stakeholder Impact

• Minimal impact on shareholders as the transaction is a routine tax compliance measure.

Next Steps

• Future vesting of restricted shares scheduled through June 2029.

Key Dates

Keywords

STERIS, STE, Form 4, Insider Trading, Equity Vesting, Tax Withholding